FDA 483 - Biotika a.s. - June 01, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Biotika A.S., an API manufacturer in Slovenska Lupca, Slovakia, revealed significant deficiencies in documentation practices. Observations included incomplete batch production and control records, specifically regarding in-process test results, cleanroom parameters, and water volumes. The firm also failed to adequately document changes to computerized systems, review audit trails, and control user roles, indicating serious data integrity concerns.
ID · e49a8405-f2ff-4f1b-aaf5-285b0fc6a49c